ClaripulseClaripulse
MAUDE LookupResourcesBlog
LoginGet Early Access
ClaripulseClaripulse

Product

MAUDE LookupDashboard

Guides

FDA MAUDE DatabasePost-Market SurveillanceSignal Detection

Learn

BlogResourcesWhy Claripulse?

Legal

Privacy PolicyTerms of Service

This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified — do not attempt re-identification. © 2026 Claripulse.

Back to Structural Heart
MAUDE LookupStructural HeartPASCAL

PASCAL Adverse Events: FDA MAUDE Data

Edwards Lifesciences LLC · Transcatheter Mitral Valve Repair (TEER) · First cleared Sep 2022

Total Reports

1,559

Reports (30d)

955

Active Signals

3

Open Recalls

1

Monthly Report Volume
Event Type Breakdown

What the reports describe · Claripulse analysis

Most commonly reported problems

1

Unplanned Cardiac Surgery 48 Days Post-ProcedureEmerging

surgery intervention, cardiac surgery, position cardiac, intervention unplanned, unplanned days

109

reports

2

Cardiac Readmission 267 Days Post-ProcedureEmerging

cardiac heart, failure pod, readmission cardiac, expired pod, expired

91

reports

3

Cardiac Readmission 327 Days Post-ProcedureEmerging

cardiac heart, heart failure, readmission cardiac, failure days, position readmission

84

reports

4

Mitral Valve Reintervention 35 Days Post-ProcedureEmerging

reintervention mitral, position reintervention, mitral valve, alive, days procedure

72

reports

5

Permanent Pacemaker Implant on POD 0Emerging

status alive, pod patient, pacemaker implanted, permanent, permanent pacemaker

69

reports

6

Cardiac Readmission 18 Days Post-ProcedureEmerging

cardiac heart, heart failure, readmission cardiac, failure days, position readmission

58

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Detection

Active safety signals

Disproportionate reportinghighVolume spikecriticalIncreasing trendcritical

Regulatory

FDA recalls for this device

Class II

Jul 27, 2023 · Open, Classified

Due to a manufacturing issue, when using valve repair systems, intended to repair insufficient mitral and/or tricuspid valves, users experienced resistance when attempting to release the implant from the delivery system by rotating the release knob. Additional torque required to initiate rotation of the release wire from the implant, could cause implant rotation or additional implant implantation.

Evidence

Related research

PASCAL mitral valve repair system versus MitraClip: comparison of transcatheter edge-to-edge strategies in complex primary mitral regurgitation

Muhammed Gerçek, et al. · Clinical Research in Cardiology · 2021

Initial Experience With the PASCAL Ace Implant System for Treatment of Severe Tricuspid Regurgitation

Matthias Aurich, et al. · Circulation Cardiovascular Interventions · 2021

Transcatheter valve repair of tricuspid regurgitation with the PASCAL system: TriCLASP study 30‐day results

Stephan Baldus, et al. · Catheterization and Cardiovascular Interventions · 2022

Citations indexed from PubMed.

Keep exploring

Related devices in Structural

MitraClip

ABBOTT VASCULAR INC. · 17,746 reports

→

Edwards SAPIEN 3 Ultra Transcatheter Heart Valve

Edwards Lifesciences LLC · 13,096 reports

→

Evolut FX

MEDTRONIC, INC. · 11,918 reports

→

Evolut PRO

MEDTRONIC, INC. · 7,401 reports

→

CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS - AORTIC

Edwards Lifesciences LLC · 6,040 reports

→

CoreValve Evolut

MEDTRONIC, INC. · 4,236 reports

→

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 3 active signals detected right now.

Get Early Access

Understanding this data

What FDA MAUDE data does and does not tell you

How these reports are filed, why raw counts mislead, and the limits to know before drawing conclusions.

→

How a safety signal is detected

What the "Active Signals" count above means and the methods that separate a real signal from noise.

→
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.